Invitae Corporation’s $1.15 Billion Notes Private Placement

Invitae Corporation's $1.15 Billion Notes Private Placement

Pillsbury Winthrop Shaw Pittman LLP advised Invitae Corporation on the deal.

Invitae Corporation announced its private placement of $1.15 billion of convertible senior notes to support the company’s future growth initiatives. The investment was led by SB Management, a subsidiary of SoftBank Group Corp.

Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae’s goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time and lower prices.

The Pillsbury team was led by Corporate partner Stan Wong (Picture) and included partners Gabriella Lombardi and Mike Hird, counsel Julie Park and associates Jasmine Alves, Christopher Wing and Kendy Chan. Partner Harsha Reddy advised the team on Tax matters.

Involved fees earner: Julie Park – Paul Hastings; Jasmine Alves – Pillsbury Winthrop Shaw Pittman LLP; Kendy Chan – Pillsbury Winthrop Shaw Pittman LLP; Mike Hird – Pillsbury Winthrop Shaw Pittman LLP; Gabriella Lombardi – Pillsbury Winthrop Shaw Pittman LLP; Harsha Reddy – Pillsbury Winthrop Shaw Pittman LLP; Christopher Wing – Pillsbury Winthrop Shaw Pittman LLP; Stanton Wong – Pillsbury Winthrop Shaw Pittman LLP;

Law Firms: Paul Hastings; Pillsbury Winthrop Shaw Pittman LLP;

Clients: Invitae Corp;

Print Friendly, PDF & Email
Martina Bellini

Author: Martina Bellini